COVID-19 Impact on Infectious Disease Testing Kits Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Infectious Disease Testing Kits, including the following market information:
Major competitors identified in this market include Abbott Diagnostics, Abbott, Beckman Coulter Diagnostics, Roche, Siemens Healthcare, Abaxis, Acon Laboratories, Avioq, BD, Bio-Rad Laboratories, Cavidi, Cepheid, Chembio Diagnostic Systems, Clarity Diagnostics, EMD Millipore, Epitope Diagnostic, Gold Standard Diagnostics, Hologic, Immunetics, InBios International, LifETechnologies, Maxim Biomedical, Mindray, OraSure Technologies, Ortho Clinical Diagnostics, Quidel Corporation, ThermoFisherScientific, Trinity Biotech, etc.
Based on the Region:
- Global Infectious Disease Testing Kits Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Infectious Disease Testing Kits Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Infectious Disease Testing Kits Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Infectious Disease Testing Kits Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Major competitors identified in this market include Abbott Diagnostics, Abbott, Beckman Coulter Diagnostics, Roche, Siemens Healthcare, Abaxis, Acon Laboratories, Avioq, BD, Bio-Rad Laboratories, Cavidi, Cepheid, Chembio Diagnostic Systems, Clarity Diagnostics, EMD Millipore, Epitope Diagnostic, Gold Standard Diagnostics, Hologic, Immunetics, InBios International, LifETechnologies, Maxim Biomedical, Mindray, OraSure Technologies, Ortho Clinical Diagnostics, Quidel Corporation, ThermoFisherScientific, Trinity Biotech, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Molecular diagnostic test
- POCT
- Immunodiagnostic test
- HIV
- Respiratory
- HAIs
- Sexual health
- Tropical diseases
- Hepatitis
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Infectious Disease Testing Kits Industry
1.7 COVID-19 Impact: Infectious Disease Testing Kits Market Trends
2 GLOBAL INFECTIOUS DISEASE TESTING KITS QUARTERLY MARKET SIZE ANALYSIS
2.1 Infectious Disease Testing Kits Business Impact Assessment - COVID-19
2.1.1 Global Infectious Disease Testing Kits Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Infectious Disease Testing Kits Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Infectious Disease Testing Kits Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Infectious Disease Testing Kits Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Infectious Disease Testing Kits Factory Price by Manufacturers
3.3 Location of Key Manufacturers Infectious Disease Testing Kits Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Infectious Disease Testing Kits Market
3.5 Key Manufacturers Infectious Disease Testing Kits Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON INFECTIOUS DISEASE TESTING KITS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Molecular diagnostic test
1.4.2 POCT
1.4.3 Immunodiagnostic test
4.2 By Type, Global Infectious Disease Testing Kits Market Size, 2019-2021
4.2.1 By Type, Global Infectious Disease Testing Kits Market Size by Type, 2020-2021
4.2.2 By Type, Global Infectious Disease Testing Kits Price, 2020-2021
5 IMPACT OF COVID-19 ON INFECTIOUS DISEASE TESTING KITS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 HIV
5.5.2 Respiratory
5.5.3 HAIs
5.5.4 Sexual health
5.5.5 Tropical diseases
5.5.6 Hepatitis
5.2 By Application, Global Infectious Disease Testing Kits Market Size, 2019-2021
5.2.1 By Application, Global Infectious Disease Testing Kits Market Size by Application, 2019-2021
5.2.2 By Application, Global Infectious Disease Testing Kits Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Abbott Diagnostics
7.1.1 Abbott Diagnostics Business Overview
7.1.2 Abbott Diagnostics Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.1.3 Abbott Diagnostics Infectious Disease Testing Kits Product Introduction
7.1.4 Abbott Diagnostics Response to COVID-19 and Related Developments
7.2 Abbott
7.2.1 Abbott Business Overview
7.2.2 Abbott Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.2.3 Abbott Infectious Disease Testing Kits Product Introduction
7.2.4 Abbott Response to COVID-19 and Related Developments
7.3 Beckman Coulter Diagnostics
7.3.1 Beckman Coulter Diagnostics Business Overview
7.3.2 Beckman Coulter Diagnostics Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.3.3 Beckman Coulter Diagnostics Infectious Disease Testing Kits Product Introduction
7.3.4 Beckman Coulter Diagnostics Response to COVID-19 and Related Developments
7.4 Roche
7.4.1 Roche Business Overview
7.4.2 Roche Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.4.3 Roche Infectious Disease Testing Kits Product Introduction
7.4.4 Roche Response to COVID-19 and Related Developments
7.5 Siemens Healthcare
7.5.1 Siemens Healthcare Business Overview
7.5.2 Siemens Healthcare Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.5.3 Siemens Healthcare Infectious Disease Testing Kits Product Introduction
7.5.4 Siemens Healthcare Response to COVID-19 and Related Developments
7.6 Abaxis
7.6.1 Abaxis Business Overview
7.6.2 Abaxis Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.6.3 Abaxis Infectious Disease Testing Kits Product Introduction
7.6.4 Abaxis Response to COVID-19 and Related Developments
7.7 Acon Laboratories
7.7.1 Acon Laboratories Business Overview
7.7.2 Acon Laboratories Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.7.3 Acon Laboratories Infectious Disease Testing Kits Product Introduction
7.7.4 Acon Laboratories Response to COVID-19 and Related Developments
7.8 Avioq
7.8.1 Avioq Business Overview
7.8.2 Avioq Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.8.3 Avioq Infectious Disease Testing Kits Product Introduction
7.8.4 Avioq Response to COVID-19 and Related Developments
7.9 BD
7.9.1 BD Business Overview
7.9.2 BD Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.9.3 BD Infectious Disease Testing Kits Product Introduction
7.9.4 BD Response to COVID-19 and Related Developments
7.10 Bio-Rad Laboratories
7.10.1 Bio-Rad Laboratories Business Overview
7.10.2 Bio-Rad Laboratories Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.10.3 Bio-Rad Laboratories Infectious Disease Testing Kits Product Introduction
7.10.4 Bio-Rad Laboratories Response to COVID-19 and Related Developments
7.11 Cavidi
7.11.1 Cavidi Business Overview
7.11.2 Cavidi Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.11.3 Cavidi Infectious Disease Testing Kits Product Introduction
7.11.4 Cavidi Response to COVID-19 and Related Developments
7.12 Cepheid
7.12.1 Cepheid Business Overview
7.12.2 Cepheid Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.12.3 Cepheid Infectious Disease Testing Kits Product Introduction
7.12.4 Cepheid Response to COVID-19 and Related Developments
7.13 Chembio Diagnostic Systems
7.13.1 Chembio Diagnostic Systems Business Overview
7.13.2 Chembio Diagnostic Systems Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.13.3 Chembio Diagnostic Systems Infectious Disease Testing Kits Product Introduction
7.13.4 Chembio Diagnostic Systems Response to COVID-19 and Related Developments
7.14 Clarity Diagnostics
7.14.1 Clarity Diagnostics Business Overview
7.14.2 Clarity Diagnostics Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.14.3 Clarity Diagnostics Infectious Disease Testing Kits Product Introduction
7.14.4 Clarity Diagnostics Response to COVID-19 and Related Developments
7.15 EMD Millipore
7.15.1 EMD Millipore Business Overview
7.15.2 EMD Millipore Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.15.3 EMD Millipore Infectious Disease Testing Kits Product Introduction
7.15.4 EMD Millipore Response to COVID-19 and Related Developments
7.16 Epitope Diagnostic
7.16.1 Epitope Diagnostic Business Overview
7.16.2 Epitope Diagnostic Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.16.3 Epitope Diagnostic Infectious Disease Testing Kits Product Introduction
7.16.4 Epitope Diagnostic Response to COVID-19 and Related Developments
7.17 Gold Standard Diagnostics
7.17.1 Gold Standard Diagnostics Business Overview
7.17.2 Gold Standard Diagnostics Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.17.3 Gold Standard Diagnostics Infectious Disease Testing Kits Product Introduction
7.17.4 Gold Standard Diagnostics Response to COVID-19 and Related Developments
7.18 Hologic
7.18.1 Hologic Business Overview
7.18.2 Hologic Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.18.3 Hologic Infectious Disease Testing Kits Product Introduction
7.18.4 Hologic Response to COVID-19 and Related Developments
7.19 Immunetics
7.19.1 Immunetics Business Overview
7.19.2 Immunetics Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.19.3 Immunetics Infectious Disease Testing Kits Product Introduction
7.19.4 Immunetics Response to COVID-19 and Related Developments
7.20 InBios International
7.20.1 InBios International Business Overview
7.20.2 InBios International Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.20.3 InBios International Infectious Disease Testing Kits Product Introduction
7.20.4 InBios International Response to COVID-19 and Related Developments
7.21 LifETechnologies
7.21.1 LifETechnologies Business Overview
7.21.2 LifETechnologies Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.21.3 LifETechnologies Infectious Disease Testing Kits Product Introduction
7.21.4 LifETechnologies Response to COVID-19 and Related Developments
7.22 Maxim Biomedical
7.22.1 Maxim Biomedical Business Overview
7.22.2 Maxim Biomedical Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.22.3 Maxim Biomedical Infectious Disease Testing Kits Product Introduction
7.22.4 Maxim Biomedical Response to COVID-19 and Related Developments
7.23 Mindray
7.23.1 Mindray Business Overview
7.23.2 Mindray Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.23.3 Mindray Infectious Disease Testing Kits Product Introduction
7.23.4 Mindray Response to COVID-19 and Related Developments
7.24 OraSure Technologies
7.24.1 OraSure Technologies Business Overview
7.24.2 OraSure Technologies Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.24.3 OraSure Technologies Infectious Disease Testing Kits Product Introduction
7.24.4 OraSure Technologies Response to COVID-19 and Related Developments
7.25 Ortho Clinical Diagnostics
7.25.1 Ortho Clinical Diagnostics Business Overview
7.25.2 Ortho Clinical Diagnostics Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.25.3 Ortho Clinical Diagnostics Infectious Disease Testing Kits Product Introduction
7.25.4 Ortho Clinical Diagnostics Response to COVID-19 and Related Developments
7.26 Quidel Corporation
7.26.1 Quidel Corporation Business Overview
7.26.2 Quidel Corporation Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.26.3 Quidel Corporation Infectious Disease Testing Kits Product Introduction
7.26.4 Quidel Corporation Response to COVID-19 and Related Developments
7.27 ThermoFisherScientific
7.27.1 ThermoFisherScientific Business Overview
7.27.2 ThermoFisherScientific Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.27.3 ThermoFisherScientific Infectious Disease Testing Kits Product Introduction
7.27.4 ThermoFisherScientific Response to COVID-19 and Related Developments
7.28 Trinity Biotech
7.28.1 Trinity Biotech Business Overview
7.28.2 Trinity Biotech Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.28.3 Trinity Biotech Infectious Disease Testing Kits Product Introduction
7.28.4 Trinity Biotech Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Infectious Disease Testing Kits Supply Chain Analysis
8.1.1 Infectious Disease Testing Kits Supply Chain Analysis
8.1.2 Covid-19 Impact on Infectious Disease Testing Kits Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Infectious Disease Testing Kits Distribution Channels
8.2.2 Covid-19 Impact on Infectious Disease Testing Kits Distribution Channels
8.2.3 Infectious Disease Testing Kits Distributors
8.3 Infectious Disease Testing Kits Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Infectious Disease Testing Kits Industry
1.7 COVID-19 Impact: Infectious Disease Testing Kits Market Trends
2 GLOBAL INFECTIOUS DISEASE TESTING KITS QUARTERLY MARKET SIZE ANALYSIS
2.1 Infectious Disease Testing Kits Business Impact Assessment - COVID-19
2.1.1 Global Infectious Disease Testing Kits Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Infectious Disease Testing Kits Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Infectious Disease Testing Kits Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Infectious Disease Testing Kits Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Infectious Disease Testing Kits Factory Price by Manufacturers
3.3 Location of Key Manufacturers Infectious Disease Testing Kits Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Infectious Disease Testing Kits Market
3.5 Key Manufacturers Infectious Disease Testing Kits Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON INFECTIOUS DISEASE TESTING KITS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Molecular diagnostic test
1.4.2 POCT
1.4.3 Immunodiagnostic test
4.2 By Type, Global Infectious Disease Testing Kits Market Size, 2019-2021
4.2.1 By Type, Global Infectious Disease Testing Kits Market Size by Type, 2020-2021
4.2.2 By Type, Global Infectious Disease Testing Kits Price, 2020-2021
5 IMPACT OF COVID-19 ON INFECTIOUS DISEASE TESTING KITS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 HIV
5.5.2 Respiratory
5.5.3 HAIs
5.5.4 Sexual health
5.5.5 Tropical diseases
5.5.6 Hepatitis
5.2 By Application, Global Infectious Disease Testing Kits Market Size, 2019-2021
5.2.1 By Application, Global Infectious Disease Testing Kits Market Size by Application, 2019-2021
5.2.2 By Application, Global Infectious Disease Testing Kits Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Abbott Diagnostics
7.1.1 Abbott Diagnostics Business Overview
7.1.2 Abbott Diagnostics Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.1.3 Abbott Diagnostics Infectious Disease Testing Kits Product Introduction
7.1.4 Abbott Diagnostics Response to COVID-19 and Related Developments
7.2 Abbott
7.2.1 Abbott Business Overview
7.2.2 Abbott Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.2.3 Abbott Infectious Disease Testing Kits Product Introduction
7.2.4 Abbott Response to COVID-19 and Related Developments
7.3 Beckman Coulter Diagnostics
7.3.1 Beckman Coulter Diagnostics Business Overview
7.3.2 Beckman Coulter Diagnostics Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.3.3 Beckman Coulter Diagnostics Infectious Disease Testing Kits Product Introduction
7.3.4 Beckman Coulter Diagnostics Response to COVID-19 and Related Developments
7.4 Roche
7.4.1 Roche Business Overview
7.4.2 Roche Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.4.3 Roche Infectious Disease Testing Kits Product Introduction
7.4.4 Roche Response to COVID-19 and Related Developments
7.5 Siemens Healthcare
7.5.1 Siemens Healthcare Business Overview
7.5.2 Siemens Healthcare Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.5.3 Siemens Healthcare Infectious Disease Testing Kits Product Introduction
7.5.4 Siemens Healthcare Response to COVID-19 and Related Developments
7.6 Abaxis
7.6.1 Abaxis Business Overview
7.6.2 Abaxis Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.6.3 Abaxis Infectious Disease Testing Kits Product Introduction
7.6.4 Abaxis Response to COVID-19 and Related Developments
7.7 Acon Laboratories
7.7.1 Acon Laboratories Business Overview
7.7.2 Acon Laboratories Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.7.3 Acon Laboratories Infectious Disease Testing Kits Product Introduction
7.7.4 Acon Laboratories Response to COVID-19 and Related Developments
7.8 Avioq
7.8.1 Avioq Business Overview
7.8.2 Avioq Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.8.3 Avioq Infectious Disease Testing Kits Product Introduction
7.8.4 Avioq Response to COVID-19 and Related Developments
7.9 BD
7.9.1 BD Business Overview
7.9.2 BD Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.9.3 BD Infectious Disease Testing Kits Product Introduction
7.9.4 BD Response to COVID-19 and Related Developments
7.10 Bio-Rad Laboratories
7.10.1 Bio-Rad Laboratories Business Overview
7.10.2 Bio-Rad Laboratories Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.10.3 Bio-Rad Laboratories Infectious Disease Testing Kits Product Introduction
7.10.4 Bio-Rad Laboratories Response to COVID-19 and Related Developments
7.11 Cavidi
7.11.1 Cavidi Business Overview
7.11.2 Cavidi Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.11.3 Cavidi Infectious Disease Testing Kits Product Introduction
7.11.4 Cavidi Response to COVID-19 and Related Developments
7.12 Cepheid
7.12.1 Cepheid Business Overview
7.12.2 Cepheid Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.12.3 Cepheid Infectious Disease Testing Kits Product Introduction
7.12.4 Cepheid Response to COVID-19 and Related Developments
7.13 Chembio Diagnostic Systems
7.13.1 Chembio Diagnostic Systems Business Overview
7.13.2 Chembio Diagnostic Systems Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.13.3 Chembio Diagnostic Systems Infectious Disease Testing Kits Product Introduction
7.13.4 Chembio Diagnostic Systems Response to COVID-19 and Related Developments
7.14 Clarity Diagnostics
7.14.1 Clarity Diagnostics Business Overview
7.14.2 Clarity Diagnostics Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.14.3 Clarity Diagnostics Infectious Disease Testing Kits Product Introduction
7.14.4 Clarity Diagnostics Response to COVID-19 and Related Developments
7.15 EMD Millipore
7.15.1 EMD Millipore Business Overview
7.15.2 EMD Millipore Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.15.3 EMD Millipore Infectious Disease Testing Kits Product Introduction
7.15.4 EMD Millipore Response to COVID-19 and Related Developments
7.16 Epitope Diagnostic
7.16.1 Epitope Diagnostic Business Overview
7.16.2 Epitope Diagnostic Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.16.3 Epitope Diagnostic Infectious Disease Testing Kits Product Introduction
7.16.4 Epitope Diagnostic Response to COVID-19 and Related Developments
7.17 Gold Standard Diagnostics
7.17.1 Gold Standard Diagnostics Business Overview
7.17.2 Gold Standard Diagnostics Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.17.3 Gold Standard Diagnostics Infectious Disease Testing Kits Product Introduction
7.17.4 Gold Standard Diagnostics Response to COVID-19 and Related Developments
7.18 Hologic
7.18.1 Hologic Business Overview
7.18.2 Hologic Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.18.3 Hologic Infectious Disease Testing Kits Product Introduction
7.18.4 Hologic Response to COVID-19 and Related Developments
7.19 Immunetics
7.19.1 Immunetics Business Overview
7.19.2 Immunetics Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.19.3 Immunetics Infectious Disease Testing Kits Product Introduction
7.19.4 Immunetics Response to COVID-19 and Related Developments
7.20 InBios International
7.20.1 InBios International Business Overview
7.20.2 InBios International Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.20.3 InBios International Infectious Disease Testing Kits Product Introduction
7.20.4 InBios International Response to COVID-19 and Related Developments
7.21 LifETechnologies
7.21.1 LifETechnologies Business Overview
7.21.2 LifETechnologies Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.21.3 LifETechnologies Infectious Disease Testing Kits Product Introduction
7.21.4 LifETechnologies Response to COVID-19 and Related Developments
7.22 Maxim Biomedical
7.22.1 Maxim Biomedical Business Overview
7.22.2 Maxim Biomedical Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.22.3 Maxim Biomedical Infectious Disease Testing Kits Product Introduction
7.22.4 Maxim Biomedical Response to COVID-19 and Related Developments
7.23 Mindray
7.23.1 Mindray Business Overview
7.23.2 Mindray Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.23.3 Mindray Infectious Disease Testing Kits Product Introduction
7.23.4 Mindray Response to COVID-19 and Related Developments
7.24 OraSure Technologies
7.24.1 OraSure Technologies Business Overview
7.24.2 OraSure Technologies Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.24.3 OraSure Technologies Infectious Disease Testing Kits Product Introduction
7.24.4 OraSure Technologies Response to COVID-19 and Related Developments
7.25 Ortho Clinical Diagnostics
7.25.1 Ortho Clinical Diagnostics Business Overview
7.25.2 Ortho Clinical Diagnostics Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.25.3 Ortho Clinical Diagnostics Infectious Disease Testing Kits Product Introduction
7.25.4 Ortho Clinical Diagnostics Response to COVID-19 and Related Developments
7.26 Quidel Corporation
7.26.1 Quidel Corporation Business Overview
7.26.2 Quidel Corporation Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.26.3 Quidel Corporation Infectious Disease Testing Kits Product Introduction
7.26.4 Quidel Corporation Response to COVID-19 and Related Developments
7.27 ThermoFisherScientific
7.27.1 ThermoFisherScientific Business Overview
7.27.2 ThermoFisherScientific Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.27.3 ThermoFisherScientific Infectious Disease Testing Kits Product Introduction
7.27.4 ThermoFisherScientific Response to COVID-19 and Related Developments
7.28 Trinity Biotech
7.28.1 Trinity Biotech Business Overview
7.28.2 Trinity Biotech Infectious Disease Testing Kits Quarterly Production and Revenue, 2020
7.28.3 Trinity Biotech Infectious Disease Testing Kits Product Introduction
7.28.4 Trinity Biotech Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Infectious Disease Testing Kits Supply Chain Analysis
8.1.1 Infectious Disease Testing Kits Supply Chain Analysis
8.1.2 Covid-19 Impact on Infectious Disease Testing Kits Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Infectious Disease Testing Kits Distribution Channels
8.2.2 Covid-19 Impact on Infectious Disease Testing Kits Distribution Channels
8.2.3 Infectious Disease Testing Kits Distributors
8.3 Infectious Disease Testing Kits Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Infectious Disease Testing Kits Assessment
Table 9. COVID-19 Impact: Infectious Disease Testing Kits Market Trends
Table 10. COVID-19 Impact Global Infectious Disease Testing Kits Market Size
Table 11. Global Infectious Disease Testing Kits Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Infectious Disease Testing Kits Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Infectious Disease Testing Kits Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Infectious Disease Testing Kits Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Infectious Disease Testing Kits Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Infectious Disease Testing Kits Market Growth Drivers
Table 17. Global Infectious Disease Testing Kits Market Restraints
Table 18. Global Infectious Disease Testing Kits Market Opportunities
Table 19. Global Infectious Disease Testing Kits Market Challenges
Table 20. Key Manufacturers Infectious Disease Testing Kits Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Infectious Disease Testing Kits Market Size, 2019 (K Units) & (US$ Million)
Table 22. Infectious Disease Testing Kits Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Infectious Disease Testing Kits Manufacturing Plants
Table 24. Key Manufacturers Infectious Disease Testing Kits Market Served
Table 25. Date of Key Manufacturers Enter into Infectious Disease Testing Kits Market
Table 26. Key Manufacturers Infectious Disease Testing Kits Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Infectious Disease Testing Kits Market Size by Type, 2020, (US$ Million)
Table 29. Global Infectious Disease Testing Kits Market Size by Type, 2020 (K Units)
Table 30. Global Infectious Disease Testing Kits Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Infectious Disease Testing Kits Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Infectious Disease Testing Kits Market Size by Application, 2020-2021 (K Units)
Table 33. Global Infectious Disease Testing Kits Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Infectious Disease Testing Kits Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Infectious Disease Testing Kits Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Infectious Disease Testing Kits Market Size, 2019-2021 (K Units)
Table 38. US Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Infectious Disease Testing Kits Market Size, 2019-2021 (K Units)
Table 43. Germany Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Infectious Disease Testing Kits Market Size, 2019-2021 (K Units)
Table 50. China Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Abbott Diagnostics Business Overview
Table 58. Abbott Diagnostics Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Abbott Diagnostics Infectious Disease Testing Kits Product
Table 60. Abbott Diagnostics Response to COVID-19 and Related Developments
Table 61. Abbott Business Overview
Table 62. Abbott Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Abbott Infectious Disease Testing Kits Product
Table 64. Abbott Response to COVID-19 and Related Developments
Table 65. Beckman Coulter Diagnostics Business Overview
Table 66. Beckman Coulter Diagnostics Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Beckman Coulter Diagnostics Infectious Disease Testing Kits Product
Table 68. Beckman Coulter Diagnostics Response to COVID-19 and Related Developments
Table 69. Roche Business Overview
Table 70. Roche Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Roche Infectious Disease Testing Kits Product
Table 72. Roche Response to COVID-19 and Related Developments
Table 73. Siemens Healthcare Business Overview
Table 74. Siemens Healthcare Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Siemens Healthcare Infectious Disease Testing Kits Product
Table 76. Siemens Healthcare Response to COVID-19 and Related Developments
Table 77. Abaxis Business Overview
Table 78. Abaxis Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Abaxis Infectious Disease Testing Kits Product
Table 80. Abaxis Response to COVID-19 and Related Developments
Table 81. Acon Laboratories Business Overview
Table 82. Acon Laboratories Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Acon Laboratories Infectious Disease Testing Kits Product
Table 84. Acon Laboratories Response to COVID-19 and Related Developments
Table 85. Avioq Business Overview
Table 86. Avioq Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Avioq Infectious Disease Testing Kits Product
Table 88. Avioq Response to COVID-19 and Related Developments
Table 89. BD Business Overview
Table 90. BD Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. BD Infectious Disease Testing Kits Product
Table 92. BD Response to COVID-19 and Related Developments
Table 93. Bio-Rad Laboratories Business Overview
Table 94. Bio-Rad Laboratories Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Bio-Rad Laboratories Infectious Disease Testing Kits Product
Table 96. Bio-Rad Laboratories Response to COVID-19 and Related Developments
Table 97. Cavidi Business Overview
Table 98. Cavidi Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Cavidi Infectious Disease Testing Kits Product
Table 100. Cavidi Response to COVID-19 and Related Developments
Table 101. Cepheid Business Overview
Table 102. Cepheid Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Cepheid Infectious Disease Testing Kits Product
Table 104. Cepheid Response to COVID-19 and Related Developments
Table 105. Chembio Diagnostic Systems Business Overview
Table 106. Chembio Diagnostic Systems Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Chembio Diagnostic Systems Infectious Disease Testing Kits Product
Table 108. Chembio Diagnostic Systems Response to COVID-19 and Related Developments
Table 109. Clarity Diagnostics Business Overview
Table 110. Clarity Diagnostics Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. Clarity Diagnostics Infectious Disease Testing Kits Product
Table 112. Clarity Diagnostics Response to COVID-19 and Related Developments
Table 113. EMD Millipore Business Overview
Table 114. EMD Millipore Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 115. EMD Millipore Infectious Disease Testing Kits Product
Table 116. EMD Millipore Response to COVID-19 and Related Developments
Table 117. Epitope Diagnostic Business Overview
Table 118. Epitope Diagnostic Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 119. Epitope Diagnostic Infectious Disease Testing Kits Product
Table 120. Epitope Diagnostic Response to COVID-19 and Related Developments
Table 121. Gold Standard Diagnostics Business Overview
Table 122. Gold Standard Diagnostics Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 123. Gold Standard Diagnostics Infectious Disease Testing Kits Product
Table 124. Gold Standard Diagnostics Response to COVID-19 and Related Developments
Table 125. Hologic Business Overview
Table 126. Hologic Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 127. Hologic Infectious Disease Testing Kits Product
Table 128. Hologic Response to COVID-19 and Related Developments
Table 129. Immunetics Business Overview
Table 130. Immunetics Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 131. Immunetics Infectious Disease Testing Kits Product
Table 132. Immunetics Response to COVID-19 and Related Developments
Table 133. InBios International Business Overview
Table 134. InBios International Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 135. InBios International Infectious Disease Testing Kits Product
Table 136. InBios International Response to COVID-19 and Related Developments
Table 137. LifETechnologies Business Overview
Table 138. LifETechnologies Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 139. LifETechnologies Infectious Disease Testing Kits Product
Table 140. LifETechnologies Response to COVID-19 and Related Developments
Table 141. Maxim Biomedical Business Overview
Table 142. Maxim Biomedical Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 143. Maxim Biomedical Infectious Disease Testing Kits Product
Table 144. Maxim Biomedical Response to COVID-19 and Related Developments
Table 145. Mindray Business Overview
Table 146. Mindray Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 147. Mindray Infectious Disease Testing Kits Product
Table 148. Mindray Response to COVID-19 and Related Developments
Table 149. OraSure Technologies Business Overview
Table 150. OraSure Technologies Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 151. OraSure Technologies Infectious Disease Testing Kits Product
Table 152. OraSure Technologies Response to COVID-19 and Related Developments
Table 153. Ortho Clinical Diagnostics Business Overview
Table 154. Ortho Clinical Diagnostics Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 155. Ortho Clinical Diagnostics Infectious Disease Testing Kits Product
Table 156. Ortho Clinical Diagnostics Response to COVID-19 and Related Developments
Table 157. Quidel Corporation Business Overview
Table 158. Quidel Corporation Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 159. Quidel Corporation Infectious Disease Testing Kits Product
Table 160. Quidel Corporation Response to COVID-19 and Related Developments
Table 161. ThermoFisherScientific Business Overview
Table 162. ThermoFisherScientific Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 163. ThermoFisherScientific Infectious Disease Testing Kits Product
Table 164. ThermoFisherScientific Response to COVID-19 and Related Developments
Table 165. Trinity Biotech Business Overview
Table 166. Trinity Biotech Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 167. Trinity Biotech Infectious Disease Testing Kits Product
Table 168. Trinity Biotech Response to COVID-19 and Related Developments
Table 169. Infectious Disease Testing Kits Distributors List
Table 170. Infectious Disease Testing Kits Customers List
Table 171. Covid-19 Impact on Infectious Disease Testing Kits Customers
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Infectious Disease Testing Kits Assessment
Table 9. COVID-19 Impact: Infectious Disease Testing Kits Market Trends
Table 10. COVID-19 Impact Global Infectious Disease Testing Kits Market Size
Table 11. Global Infectious Disease Testing Kits Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Infectious Disease Testing Kits Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Infectious Disease Testing Kits Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Infectious Disease Testing Kits Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Infectious Disease Testing Kits Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Infectious Disease Testing Kits Market Growth Drivers
Table 17. Global Infectious Disease Testing Kits Market Restraints
Table 18. Global Infectious Disease Testing Kits Market Opportunities
Table 19. Global Infectious Disease Testing Kits Market Challenges
Table 20. Key Manufacturers Infectious Disease Testing Kits Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Infectious Disease Testing Kits Market Size, 2019 (K Units) & (US$ Million)
Table 22. Infectious Disease Testing Kits Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Infectious Disease Testing Kits Manufacturing Plants
Table 24. Key Manufacturers Infectious Disease Testing Kits Market Served
Table 25. Date of Key Manufacturers Enter into Infectious Disease Testing Kits Market
Table 26. Key Manufacturers Infectious Disease Testing Kits Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Infectious Disease Testing Kits Market Size by Type, 2020, (US$ Million)
Table 29. Global Infectious Disease Testing Kits Market Size by Type, 2020 (K Units)
Table 30. Global Infectious Disease Testing Kits Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Infectious Disease Testing Kits Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Infectious Disease Testing Kits Market Size by Application, 2020-2021 (K Units)
Table 33. Global Infectious Disease Testing Kits Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Infectious Disease Testing Kits Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Infectious Disease Testing Kits Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Infectious Disease Testing Kits Market Size, 2019-2021 (K Units)
Table 38. US Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Infectious Disease Testing Kits Market Size, 2019-2021 (K Units)
Table 43. Germany Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Infectious Disease Testing Kits Market Size, 2019-2021 (K Units)
Table 50. China Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Infectious Disease Testing Kits Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Abbott Diagnostics Business Overview
Table 58. Abbott Diagnostics Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Abbott Diagnostics Infectious Disease Testing Kits Product
Table 60. Abbott Diagnostics Response to COVID-19 and Related Developments
Table 61. Abbott Business Overview
Table 62. Abbott Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Abbott Infectious Disease Testing Kits Product
Table 64. Abbott Response to COVID-19 and Related Developments
Table 65. Beckman Coulter Diagnostics Business Overview
Table 66. Beckman Coulter Diagnostics Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Beckman Coulter Diagnostics Infectious Disease Testing Kits Product
Table 68. Beckman Coulter Diagnostics Response to COVID-19 and Related Developments
Table 69. Roche Business Overview
Table 70. Roche Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Roche Infectious Disease Testing Kits Product
Table 72. Roche Response to COVID-19 and Related Developments
Table 73. Siemens Healthcare Business Overview
Table 74. Siemens Healthcare Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Siemens Healthcare Infectious Disease Testing Kits Product
Table 76. Siemens Healthcare Response to COVID-19 and Related Developments
Table 77. Abaxis Business Overview
Table 78. Abaxis Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Abaxis Infectious Disease Testing Kits Product
Table 80. Abaxis Response to COVID-19 and Related Developments
Table 81. Acon Laboratories Business Overview
Table 82. Acon Laboratories Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Acon Laboratories Infectious Disease Testing Kits Product
Table 84. Acon Laboratories Response to COVID-19 and Related Developments
Table 85. Avioq Business Overview
Table 86. Avioq Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Avioq Infectious Disease Testing Kits Product
Table 88. Avioq Response to COVID-19 and Related Developments
Table 89. BD Business Overview
Table 90. BD Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. BD Infectious Disease Testing Kits Product
Table 92. BD Response to COVID-19 and Related Developments
Table 93. Bio-Rad Laboratories Business Overview
Table 94. Bio-Rad Laboratories Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Bio-Rad Laboratories Infectious Disease Testing Kits Product
Table 96. Bio-Rad Laboratories Response to COVID-19 and Related Developments
Table 97. Cavidi Business Overview
Table 98. Cavidi Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Cavidi Infectious Disease Testing Kits Product
Table 100. Cavidi Response to COVID-19 and Related Developments
Table 101. Cepheid Business Overview
Table 102. Cepheid Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Cepheid Infectious Disease Testing Kits Product
Table 104. Cepheid Response to COVID-19 and Related Developments
Table 105. Chembio Diagnostic Systems Business Overview
Table 106. Chembio Diagnostic Systems Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Chembio Diagnostic Systems Infectious Disease Testing Kits Product
Table 108. Chembio Diagnostic Systems Response to COVID-19 and Related Developments
Table 109. Clarity Diagnostics Business Overview
Table 110. Clarity Diagnostics Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. Clarity Diagnostics Infectious Disease Testing Kits Product
Table 112. Clarity Diagnostics Response to COVID-19 and Related Developments
Table 113. EMD Millipore Business Overview
Table 114. EMD Millipore Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 115. EMD Millipore Infectious Disease Testing Kits Product
Table 116. EMD Millipore Response to COVID-19 and Related Developments
Table 117. Epitope Diagnostic Business Overview
Table 118. Epitope Diagnostic Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 119. Epitope Diagnostic Infectious Disease Testing Kits Product
Table 120. Epitope Diagnostic Response to COVID-19 and Related Developments
Table 121. Gold Standard Diagnostics Business Overview
Table 122. Gold Standard Diagnostics Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 123. Gold Standard Diagnostics Infectious Disease Testing Kits Product
Table 124. Gold Standard Diagnostics Response to COVID-19 and Related Developments
Table 125. Hologic Business Overview
Table 126. Hologic Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 127. Hologic Infectious Disease Testing Kits Product
Table 128. Hologic Response to COVID-19 and Related Developments
Table 129. Immunetics Business Overview
Table 130. Immunetics Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 131. Immunetics Infectious Disease Testing Kits Product
Table 132. Immunetics Response to COVID-19 and Related Developments
Table 133. InBios International Business Overview
Table 134. InBios International Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 135. InBios International Infectious Disease Testing Kits Product
Table 136. InBios International Response to COVID-19 and Related Developments
Table 137. LifETechnologies Business Overview
Table 138. LifETechnologies Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 139. LifETechnologies Infectious Disease Testing Kits Product
Table 140. LifETechnologies Response to COVID-19 and Related Developments
Table 141. Maxim Biomedical Business Overview
Table 142. Maxim Biomedical Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 143. Maxim Biomedical Infectious Disease Testing Kits Product
Table 144. Maxim Biomedical Response to COVID-19 and Related Developments
Table 145. Mindray Business Overview
Table 146. Mindray Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 147. Mindray Infectious Disease Testing Kits Product
Table 148. Mindray Response to COVID-19 and Related Developments
Table 149. OraSure Technologies Business Overview
Table 150. OraSure Technologies Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 151. OraSure Technologies Infectious Disease Testing Kits Product
Table 152. OraSure Technologies Response to COVID-19 and Related Developments
Table 153. Ortho Clinical Diagnostics Business Overview
Table 154. Ortho Clinical Diagnostics Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 155. Ortho Clinical Diagnostics Infectious Disease Testing Kits Product
Table 156. Ortho Clinical Diagnostics Response to COVID-19 and Related Developments
Table 157. Quidel Corporation Business Overview
Table 158. Quidel Corporation Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 159. Quidel Corporation Infectious Disease Testing Kits Product
Table 160. Quidel Corporation Response to COVID-19 and Related Developments
Table 161. ThermoFisherScientific Business Overview
Table 162. ThermoFisherScientific Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 163. ThermoFisherScientific Infectious Disease Testing Kits Product
Table 164. ThermoFisherScientific Response to COVID-19 and Related Developments
Table 165. Trinity Biotech Business Overview
Table 166. Trinity Biotech Infectious Disease Testing Kits Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 167. Trinity Biotech Infectious Disease Testing Kits Product
Table 168. Trinity Biotech Response to COVID-19 and Related Developments
Table 169. Infectious Disease Testing Kits Distributors List
Table 170. Infectious Disease Testing Kits Customers List
Table 171. Covid-19 Impact on Infectious Disease Testing Kits Customers
LIST OF FIGURES
Figure 1. Infectious Disease Testing Kits Product Picture
Figure 2. Infectious Disease Testing Kits Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Infectious Disease Testing Kits Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Infectious Disease Testing Kits Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Infectious Disease Testing Kits Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Infectious Disease Testing Kits Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Infectious Disease Testing Kits Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Infectious Disease Testing Kits Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Infectious Disease Testing Kits Market Size Market Share, 2019-2021
Figure 1. Infectious Disease Testing Kits Product Picture
Figure 2. Infectious Disease Testing Kits Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Infectious Disease Testing Kits Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Infectious Disease Testing Kits Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Infectious Disease Testing Kits Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Infectious Disease Testing Kits Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Infectious Disease Testing Kits Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Infectious Disease Testing Kits Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Infectious Disease Testing Kits Market Size Market Share, 2019-2021
